To support their possible roles in crucial oncogenic mechanisms, we assessed the mutation frequency, copy number amplification, and copy number–expression correlation of STC2, MIF, CD74, CXCR4, GDF15, and TGFBR2 across several cancer types (Supplementary Fig. S4A–C). The gene discussed is TGFBR2; the disease is cancer.